Skip to content

Public FDA record

Z-0661-2022: IPELA FHD PTZ TILE KITS with Axis cameras used in combination with Natus Neuroworks/Sleepworks software

Recall record Z-0661-2022 for Natus Neurology DBA Excel Tech., Ltd. (XLTEK). View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0661-2022
Company in FDA record
Natus Neurology DBA Excel Tech., Ltd. (XLTEK)
FDA record creation date
Feb 22, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Tile kits that allow one to install and situate a video camera within a patient environment are not fitting properly in some domestic institution ceiling tile grids that have a thinner style grid frame. The ceiling tile may suddenly fall from the ceiling and cause a safety risk to the patient or end user.

Source facts

Action
On 12/02/21, correction notices were mailed to customers informing them to stop using this device immediately until a solution to this issue is found. On 12/08/21, correction notices were mailed to customers informing them to follow the steps in document DOC-057825 IPELA FHD PTZ TILE KITS Correction to install Safety Wires on ceilings that meet the following structural requirements: 1) Ceilings must have existing 2' x 2' (609.6 mm x 609.6mm) ceiling tile. 2) Tile Kits ceiling tile is only compatible with a 15/16" (23.8 mm) grid tee. 3) The suspended ceiling grid must be able to support the full weight of the TILE KITS ceiling tile of 19 lbs (8.6 kg) without exceeding its loading capacity. 4) Install safety wires following instructions. Customers were asked to complete the customer reply form and to email it to FCA@Natus.com Customers with questions were provided the following phone number: 800-387-7516 Customers were asked to pass the correction notice to all those who need to be aware within their organization or to any organization where the potentially affected devices may have been transferred.
Initiated
2021-12-02
Root cause
Process change control
Terminated
2024-09-18
Distribution
Worldwide distribution - US Nationwide distribution in the states of FL, IL, TX, MI, MA, NE, OK, WV, MO, VA, CT, IN, HI, PA, CA, MD, OH, CO, SC, PR, NV, NJ, OR, LA, DC, NC and the countries of Nepal, Viet Nam, Canada, Saudi Arabia, Indonesia, Germany, Korea, Republic of
Recall number
Z-0661-2022
Recall status
Terminated
CDRH record ID
191527
FDA record created
2022-02-22
Recall event number
89425

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗